ReviewBundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz2022
[Psychosocial long-term effects of cancer].
Review in Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- The elicitation of quality of life preferences for lung cancer treatment from the perspective of patients and treating physicians: results of two discrete choice experiments.The European journal of health economics : HEPAC : health economics in prevention and care · 2026Article
- Article
- Therapeutic potential and mechanisms of rehabilitation interventions in preventing cancer metastasis.Frontiers in oncology · 2026Review
- [Validation of subjective complaints: differential diagnosis of "healthy suffering" using fatigue as an example].Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Incidence rates for cancer have increased in Western countries in recent decades, and the number of new cases in Germany is estimated at about 500,000 per year. Due to early detection of cancer and improved treatment strategies, survival time has improved for most cancer diagnoses. Therefore, the number of long-term cancer survivors (≥ 5 years after diagnosis) has also increased. Despite the advances in oncology, a substantial percentage of long-term survivors show reduced quality of life and suffering from various sequelae of cancer and its treatment. This review focuses on the most common psychological issues of long-term survivors such as anxiety and depression, psychosocial aspects of quality of life, neuropsychological deficits, and fatigue. Finally, recommendations are given for psychosocial interventions and improvements to the psychosocial care of long-term survivors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.